Aegis capital corp. acted as exclusive placement agent on a $3.25 million registered direct & private placement for avenue therapeutics, inc. (nasdaq:atxi)

New york, ny / accesswire / january 31, 2023 / aegis capital corp. acted as exclusive placement agent on a $3.25 million registered direct & private placement for avenue therapeutics, inc. (nasdaq:atxi). about avenue therapeutics, inc. avenue therapeutics, inc. (nasdaq:atxi) is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of central nervous system diseases.
ATXI Ratings Summary
ATXI Quant Ranking